18 hrs ago | Myrtle Beach Online
Residents still await quarry's response
Robert Ravenell spent every morning for two weeks outside the limestone quarry he said put cracks in the bricks of his house.
Amylin Pharmaceuticals got a triple dose of good news over the weekend. Individually, each update might not have amounted to much, but together they were good for a 10% pop in the company's shares yesterday.
S.C. limiting some Medicaid patients to one drugstore
South Carolina, trying to curb abuse of narcotics and save money, is requiring Medicaid patients suspected of doctor-hopping for drugs to choose one pharmacy for all of their prescriptions.
Eli Lilly Laying-Off 191 Employees
Indianapolis-based Eli Lilly plans to layoff 191 salespeople throughout the US by the end of the year.
Lilly CEO Lechleiter Calls For Repair Of The 'Engine Of...
In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D., chairman and chief executive officer of Eli Lilly and Company , said that the engine of biopharmaceutical innovation is "broken." He offered a vision for biopharmaceutical companies to "reinvent innovation" to make the most of today's wealth of scientific knowledge to ...
Eli Lilly selects ICON to provide clinical data management outside the US
ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company to manage the companya s clinical data management outside the US.
Lilly Hopes New San Diego Facility Will Be 'a Biotechnology Powerhouse'
Pharmaceutical giant Eli Lilly opened a new state-of-the-art biotechnology center in San Diego, part of an ongoing effort by the drugmaker to transform itself into a biotech titan.
Lilly Opens West Coast Biotech Center
Eli Lilly and Co. has opened its new Biotechnology Center in San Diego, as part of its strategy to develop more biopharmaceuticals.
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved an expanded indication for BYETTAA injection.
United States Attorney's Office - Eastern District of Pennsylvania
Eli Lilly and Company and the government entered into an agreement whereby Eli Lilly agrees to plead guilty to the introduction into interstate commerce of quantities of its drug, Zyprexa, that were misbranded in violation of 21 U.S.C. 331 , 333 and 352 .
Eli Lilly opens biotech center near UCSD
Pharmaceutical giant Eli Lilly and Co. on Thursday opened a biotechnology center in La Jolla that will house nearly 200 of its scientists.
November Is Lung Cancer Month: Know The Latest Information About This Deadliest Of Cancers
Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.
The Waters Aren't Flowing. Yet.
Not unlike its products that turn ugly mixtures into purer products, Waters turned an ugly top line into an acceptable earnings growth in the third quarter.
Earnings roundup: Northrop Grumman posts 3Q dip but lifts outlook, Eli Lilly turns a 3Q profit
Among the earnings stories for Wednesday, Oct. 21, from AP Financial News: WASHINGTON - Northrop Grumman Corp.
GE, Lilly deepen cancer drug effort
GE Healthcare plans to expand a cancer drug research partnership with Eli Lilly & Co., making a 2-year-old partnership official in the process.
Eli Lilly CEO banking on new drug pipeline
Eli Lilly CEO John Lechleiter thinks a reorganization announced last month will help the company withstand upcoming patent losses of some of its top-selling drugs.
Eli Lilly Loses Bid for Hearing on Evista Drug Before Canada's High Court
Eli Lilly & Co. lost a bid for a hearing before Canadaa s highest court on whether its patent for the Evista osteoporosis treatment is valid as the company tried to block Apotex Inc.
S.C. wins $45 million settlement against Eli Lilly
Attorney General Henry McMaster said today South Carolina has reached a $45 million settlement agreement with pharmaceutical giant Eli Lilly over the company's marketing of the anti-psychotic drug Zyprexa.
Bio Box: Eli Lilly CEO John Lechleiter
Name: John C. Lechleiter Occupation: chairman, president and CEO of Eli Lilly and Co.
Eli Lilly CEO Banking on New Drug Pipeline
Eli Lilly and Co.'s chairman and CEO, Leichleiter brings some of his childhood lessons to bear in leading the major drug company, which is based in Indianapolis.
Also on Topix